Aldagen revives IPO plans to raise $80.5 million

Aldagen, a small Durham company developing drugs using stem cells is reviving plans for an initial public offering of stock, hoping to take advantage of renewed Wall Street interest in biotechnology IPOs.... [more]

View complete News & Observer article